LAT staff attended a GCP EMA/FDA inspection at a site in Argentina performed in the context of the  EMA-EU MSs-FDA initiative on inspections for Generic Applications celebrated in 2014.

LAT obtained ANMAT approval for a complex Phase III study in a neurology disease in 39 working days since the implementation of the Provision 4008/17.

LAT staff participates in the Investigator Meeting of new trial awarded for acute diarrhea in children in the context of the Annual SAP Congress in Cordoba city.

LAT was awarded a new protocol in pneumonology.

LAT staff organizes a new Investigator Meeting in Buenos Aires for all sites participating in a largest pediatric study in Chagas disease in Latin America.